John A Wemmie Selected Research

Pain (Aches)

7/2013	Acid-sensing ion channels in pain and disease.
3/2010	ASIC1 and ASIC3 play different roles in the development of Hyperalgesia after inflammatory muscle injury.
9/2009	Acid-sensing ion channels: A new target for pain and CNS diseases.
10/2006	Acid-sensing ion channels: advances, questions and therapeutic opportunities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John A Wemmie Research Topics

Disease

13	Acidosis 01/2021 - 02/2003
4	Seizures (Absence Seizure) 11/2019 - 10/2006
4	Pain (Aches) 07/2013 - 10/2006
3	Bipolar Disorder (Manic Depressive Psychosis) 01/2024 - 11/2015
3	Migraine Disorders (Migraine) 10/2020 - 07/2009
3	Inflammation (Inflammations) 11/2015 - 12/2007
2	Photophobia (Light Sensitivity) 10/2020 - 07/2009
2	Mental Disorders (Mental Disorder) 11/2015 - 10/2006
2	Epilepsy (Aura) 07/2015 - 10/2012
2	Substance-Related Disorders (Drug Abuse) 09/2014 - 08/2014
2	Hypertension (High Blood Pressure) 11/2011 - 05/2011
2	Hyperalgesia 03/2010 - 12/2003
2	Ischemia 10/2006 - 09/2004
1	Bardet-Biedl Syndrome (Syndrome, Bardet-Biedl) 01/2021
1	Cognitive Dysfunction 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Mania (Manias) 11/2015
1	Apnea 07/2015
1	Drug Resistant Epilepsy 07/2015
1	Mood Disorders (Mood Disorder) 04/2014
1	Autism Spectrum Disorder 01/2013
1	Headache (Headaches) 10/2012
1	Migraine with Aura (Familial Hemiplegic Migraine) 10/2012
1	Anxiety Disorders (Anxiety Disorder) 11/2011
1	Panic Disorder (Panic Attack) 01/2011
1	Central Nervous System Diseases (CNS Diseases) 09/2009
1	Ischemic Stroke 10/2006
1	Stroke (Strokes) 09/2004
1	Hypersensitivity (Allergy) 12/2003
1	Brain Ischemia (Cerebral Ischemia) 02/2003

Drug/Important Bio-Agent (IBA)

11	Acid Sensing Ion ChannelsIBA 01/2017 - 12/2003
6	Protons (Proton)IBA 01/2021 - 10/2006
5	AcidsIBA 01/2021 - 02/2003
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2023
2	CationsIBA 01/2021 - 10/2019
2	NeuropeptidesIBA 10/2020 - 07/2009
2	Calcitonin Gene-Related PeptideIBA 10/2020 - 07/2009
2	ElementsIBA 01/2020 - 07/2008
2	Carbon DioxideIBA 10/2019 - 11/2009
2	Amiloride (Midamor)FDA LinkGeneric 10/2012 - 12/2003
2	Lactic Acid (Lactate)FDA LinkGeneric 05/2012 - 01/2011
1	LithiumIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Pentylenetetrazole (Metrazol)IBA 11/2019
1	CytokinesIBA 11/2015
1	Interleukin-4 (Interleukin 4)IBA 11/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 11/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2015
1	InterferonsIBA 11/2015
1	InterleukinsIBA 11/2015
1	Oxygen (Dioxygen)IBA 07/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2014
1	Serotonin (5 Hydroxytryptamine)IBA 04/2014
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 04/2014
1	Serotonin AgentsIBA 04/2014
1	Synapsins (Synapsin I)IBA 01/2013
1	AntioxidantsIBA 11/2011
1	CarbenoxoloneIBA 11/2011
1	tempolIBA 11/2011
1	GlucocorticoidsIBA 11/2011
1	LeptinIBA 05/2011
1	Messenger RNA (mRNA)IBA 03/2010
1	CarrageenanIBA 03/2010
1	A-317567IBA 03/2010
1	Indicators and Reagents (Reagents)IBA 07/2009
1	Receptor Activity-Modifying Protein 1IBA 07/2009
1	Neuroprotective AgentsIBA 12/2007
1	Acid Sensing Ion Channel BlockersIBA 09/2004
1	Glutamate Receptors (Glutamate Receptor)IBA 09/2004
1	Excitatory Amino Acid AntagonistsIBA 09/2004
1	CalciumIBA 09/2004
1	Glutamic Acid (Glutamate)FDA Link 09/2004

Therapy/Procedure

2	Therapeutics 08/2014 - 07/2009
1	Electrodes (Electrode) 07/2015
1	Injections 12/2003